A practical approach to intersex in the newborn period.
暂无分享,去创建一个
[1] J. Bertrand,et al. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. , 1971, The Journal of clinical endocrinology and metabolism.
[2] P. White,et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2000, Endocrine reviews.
[3] M. Ferguson-Smith,et al. PARENTAL AGE AND THE SOURCE OF THE X CHROMOSOMES IN XXY KLINEFELTER'S SYNDROME. , 1964, Lancet.
[4] P. Jacobs,et al. Klinefelter's syndrome: an analysis of the origin of the additional sex chromosome using molecular probes , 1988, Annals of human genetics.
[5] A. Sinclair,et al. Genetic evidence that ZFY is not the testis-determining factor , 1989, Nature.
[6] J. Gearhart,et al. In vitro fertilization is associated with an increased risk of hypospadias. , 1999, The Journal of urology.
[7] M. Fellous,et al. True hermaphroditism: genetic variants and clinical management. , 1994, The Journal of pediatrics.
[8] Collyer,et al. THE LANCET.: SUNDAY, OCTOBER 12, 1823 , 1823 .
[9] D. Orth.,et al. THE ADRENAL CORTEX , 1948 .
[10] M. Grumbach,et al. Cytologic tests of chromosomal sex in relation to sexual anomalies in man. , 1958, Recent progress in hormone research.
[11] Sahar Mansour,et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.
[12] M. Schwartz. The 5-Minute Pediatric Consult , 2002 .
[13] R. E. Peterson,et al. Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism , 1974, Science.
[14] M. New,et al. Congenital adrenal hyperplasia , 1993 .
[15] P. Mckenna,et al. Clinical and molecular analysis of XX sex reversed patients. , 1998, The Journal of urology.
[16] P. Pearson,et al. Nonrandom inactivation of the Y-bearing X chromosome in a 46,XX individual: evidence for the etiology of 46,XX true hermaphroditism. , 1994, Cytogenetics and cell genetics.
[17] L. Wilming,et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. , 1994, Development.
[18] W. Lenz,et al. Genetic aspects in male hypogonadism. , 1961, Recent progress in hormone research.
[19] W. Miller,et al. The genetic and functional basis of isolated 17,20–lyase deficiency , 1997, Nature Genetics.
[20] W. Miller,et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. , 1996, The New England journal of medicine.
[21] A. Braun,et al. True hermaphroditism in a 46,XY individual, caused by a postzygotic somatic point mutation in the male gonadal sex-determining locus (SRY): molecular genetics and histological findings in a sporadic case. , 1993, American journal of human genetics.
[22] P N Goodfellow,et al. SRY and sex determination in mammals. , 1993, Annual review of genetics.
[23] L. Hsu,et al. Phenotype/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. , 1994, American journal of medical genetics.
[24] K. O. Elliston,et al. Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3 , 1994, Nature Genetics.
[25] R. M. Sharpe,et al. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? , 1993, The Lancet.
[26] J. Imperato-McGinley. Sexual Differentiation: Normal and Abnormal , 1983 .
[27] S. Lumbroso,et al. A new deletion of the 5α‐reductase type 2 gene in a Turkish family with 5α‐reductase deficiency , 1995 .
[28] M. Forest,et al. Congenital adrenal hyperplasia due to point mutations in the type II 3β–hydroxysteroid dehydrogenase gene , 1992, Nature Genetics.
[29] P. Lebech,et al. Testicular feminization syndrome and associated gonadal tumors in Denmark , 1992, Acta obstetricia et gynecologica Scandinavica.
[30] J. Simard,et al. Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[31] J. Berek,et al. Dysgerminoma: the role of conservative surgery. , 1996, Gynecologic oncology.
[32] D. Housman,et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.
[33] S. Imbeaud,et al. Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families. , 1994, Human molecular genetics.
[34] P. Saenger. New developments in congenital lipoid adrenal hyperplasia and steroidogenic acute regulatory protein. , 1997, Pediatric clinics of North America.
[35] D. Porteous,et al. Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Rousseaux,et al. Achievement of meiosis in XXY germ cells: study of 543 sperm karyotypes from an XY/XXY mosaic patient , 2004, Human Genetics.
[37] R. Lovell-Badge,et al. Dax1 antagonizes Sry action in mammalian sex determination , 1998, Nature.
[38] M. Toublanc,et al. Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA‐sequences , 1994, Clinical endocrinology.
[39] N. Skakkebaek,et al. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells , 1997, Histopathology.
[40] M. Marcelli,et al. Molecular determinants of sexual differentiation , 2004, World Journal of Urology.
[41] E. Hook,et al. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism , 2004, Human Genetics.